Quantifying the gap between policy and practice in cardiovascular risk reduction: a review of evidence from recent cardiovascular and diabetes audits in the UK

As part of CHD NSF implementation, a pilot project is being undertaken under the auspices of the National Screening Committee to test the practical implications and outcomes of implementing a systematic programme of cardiovascular risk reduction in primary care, initially identifying those at high risk due to pre-existing cardiovascular disease or diabetes. To assist in assessing the magnitude of the challenge faced by the pilot programmes, the UK National Screening Committee (NSC) commissioned a review of current practice based on recent cardiovascular and diabetes audits in the UK. This report details the findings of the review, providing 6 key recommendations for future cardiovascular audits.

IPH response to Building an Active Travel Future for Northern Ireland

IPH responded to the Department for Regional Development consultation Building an Active Travel Future for Northern Ireland, March 2012 The draft Active Travel strategy seeks to set out how to increase active travel by demonstrating that walking and cycling are safe, healthy, flexible, inexpensive and social means of travel and by setting out ways in which opportunities for active travel can be significantly improved.IPH welcomes the new Active Travel Strategy and highlights the need for a truly integrated approach to the strategy which has the potential to positively influence health in areas such as obesity, mental health and cardiovascular health.  IPH suggest a health impact assessment is undertaken on each of the Active Travel Demonstration projects to fully maximise the potential health outcomes of developing the required infrastructure for active travel.

IPH response to NICE consultation on new indicators for Quality and Outcomes Framework (QOF)

IPH responded to the consultation on potential new indicators for the 2013/14 Quality and Outcomes Framework (QOF) in the UK. The 20 potential new indicators relate to chronic obstructive pulmonary disease (COPD), heart failure, coronary heart disease, diabetes, depression, hypertension, rheumatoid arthritis, asthma and cancer. The consultation asked people to consider whether there were any barriers to the implementation of the care described by any of the indicators; whether there were potential unintended consequences to the implementation of any of the indicators; whether there was potential for differential impact (in respect of age, disability, gender reassignment, pregnancy and maternity, race, religion or belief, sex and sexual orientation); and whether the indicators may have an adverse impact in different groups in the community.”

Interventions with Parents in the Early Years for improved health outcomes: A focus on behaviour and cognitive development/school readiness

Equity Action is a Joint Action between the EU and Member States aiming to reduce health inequalities by helping to improve policies at national and regional level and harness the contribution of stakeholders. Dr Cotter of IPH completed this literature review as part of Equity Action Work Package 6

Service Framework for Cardiovascular Health and Wellbeing (2014)

Welcome to the easy access version of the Service Framework for Cardiovascular Health and Wellbeing. åÊ It sets out what you can expect from the Health and Social Care (HSC) services in Northern Ireland if you have a cardiovascular illness or you care for someone who does.

Service Framework for Cardiovascular Health and Wellbeing (2009)

Standards for the treatment and care of people suffering and at risk from cardiovascular disease

Women And Cardiovascular Health

Women And Cardiovascular Health Cardiovascular disease is currently the major cause of mortality among women in Ireland. During the years 1989-1998, it was found that an average of 4,252 women in this country died from ischaemic and other heart diseases each year (Balanda and Wilde, 2001). When compared with other European Union countries, Ireland has been found to have the second highest rate of ischaemic heart disease among women, Click here to download PDF 2.4mb This is a publication of the Women’s Health Council

Women And Cardiovascular Health

Click here to download PDF

Women, Disadvantage And Cardiovascular Disease: Policy Implications - Conference Proceedings

Click here to download PDF

Building Healthier Hearts: The Report of the Cardiovascular Health Strategy Group

This introduction to "Building Healthier Hearts" will give readers an overview of the report of the Cardiovascular Health Strategy Group. Firstly, it sets out the background to the strategy and its policy context. A brief description of mortality and morbidity trends from cardiovascular disease in Ireland follows. Next an overview is given of current health service provision and of the changes considered necessary by the Group Download the Report here

Cardiovascular Disease In Women (Quality in Practice Committee)

Cardiovascular Disease In Women (Quality in Practice Committee) Cardiovascular disease (CVD) is the leading cause of mortality in men and women on a global basis. CVD affects men and women equally but evidence suggests that it is neither diagnosed as readily, nor treated as effectively, in women. Click here to download PDF 1.7mb

Changing Cardiovascular Health: National Cardiovascular Health Policy 2010 - 2019

This new cardiovascular policy, Changing Cardiovascular Health covering the period 2010-2019, comes a decade after the first national cardiovascular health strategy, entitled Building Healthier Hearts, was published by the Department of Health in 1999. The new policy is timely given the pace of scientific discovery and related changes in medical practice, changes in health service structures, and patterns and influences on population health behaviours in Ireland over the decade. Cardiovascular health and its maintenance is a microcosm of health more generally. A policy that can improve cardiovascular health and cardiovascular disease management will have beneficial effects for the whole healthcare system and population.Download this document

Northern Ireland Chest Heart & Stroke - Research Grants for 2010 in Respiratory and Cardiovascular Disease

To download an Application Form, Guidance Notes and other information, please visit the website www.nichsa.com or contact Caoimhe Devlin, Research Assistant by email: cdevlin@nichsa.com or phone: 02890 266714 / 02890 320184 ext 248.

Improving outcomes for people with skin tumours including melanoma (update)

The management of low-risk basal cell carcinomas in the community.In February 2006, the National Institute for Health and Clinical Excellence (NICE) published service guidance on skin cancer, ‘Improving outcomes for people with skin tumours including melanoma’ (NICE guidance on cancer services). Many of the recommendations in this guidance were converted into peer review measures published in the ‘Manual for cancer services 2008: skin measures..

Cardiovascular Disease in Women

Cardiovascular disease (CVD) is the leading cause of mortality in men and women on a global basis. CVD affects men and women equally but evidence suggests that it is neither diagnosed as readily, nor treated as effectively, in women. In Ireland between 2001 and 2005, an average of 2,484 women died each year from ischaemic heart disease (including myocardial infarction (MI)). (2) Yet, women seem largely unaware of their risk of developing cardiovascular disease, retaining the perception that CVD is predominantly a man's disease.